Currently, serum ALT/AST levels have been widely used as clinical markers of liver injury; although the ALT/AST measurements require fresh blood samples and lack tissue specificity, since elevated serum ALT and AST levels could be also observed in experimental models and patients with muscle or kidney diseases. The gene discussed is GPT; the disease is kidney disorder.